Scott Hutton - 10 Nov 2025 Form 4 Insider Report for BIODESIX INC (BDSX)

Reporting relationship: President & CEO, Director
Issuer ticker: BDSX
Reported as of: 10 Nov 2025
Net transaction value: -$1,440
SEC form: 4
Accepted by SEC: 13 Nov 2025, 16:53:44 UTC
Prior SEC filing: 14 Aug 2025
Next SEC filing: 06 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton

Key filing fact

Scott Hutton filed Form 4 for BIODESIX INC (BDSX) on 13 Nov 2025.

Key facts

This page summarizes Scott Hutton's Form 4 filing for BIODESIX INC (BDSX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Nov 2025, 16:53.

Change

Previous filing in this sequence was filed on 14 Aug 2025.
Current net transaction value: -$1,440.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001697361 Primary reporting owner

Hutton Scott

Relationship: President & CEO, Director
Address: 919 WEST DILLON RD, LOUISVILLE
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Scott Hutton
Signature date: 13 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDSX transaction

Common Stock

Options Exercise

Transaction value
Shares: +611
Change %: +1.7%
Price
Shares after: 37,500
Date: 10 Nov 2025
Ownership: Direct
Footnotes: F1, F2, F3

BDSX transaction

Common Stock

Sale

Transaction value: $1,440
Shares: -189
Change %: -0.5%
Price: $7.62
Shares after: 37,311
Date: 10 Nov 2025
Ownership: Direct
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDSX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -611
Change %: -50%
Price: $0.000000
Shares after: 610
Date: 10 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 611
Exercise price
Footnotes: F1, F2, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split").

Footnote F2

Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F3

Includes 448 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025.

Footnote F4

These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.

Footnote F5

These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.